Clinical Trials Logo

Lung Cancer Screening clinical trials

View clinical trials related to Lung Cancer Screening.

Filter by:

NCT ID: NCT06451029 Recruiting - Lung Cancer Clinical Trials

Prevention of Smoking Related Diseases

LSP-3
Start date: January 11, 2022
Phase:
Study type: Observational

This is a prospective, observational, monocentric study. This study wants to test if among a smoking cessation intervention, behavioural counselling by video session is related to higher compliance and higher success rate than standard smoking cessation activity (face to face counselling).

NCT ID: NCT06444373 Completed - Clinical trials for Lung Cancer Screening

Artificial Intelligence in Lung Cancer Screening

INAIL BRIC
Start date: December 2, 2022
Phase:
Study type: Observational

Single-center, non-profit, observational, retrospective study of collection of clinical and amnestic data and images to create, implement and develop a pilot model of an integrated virtual platform.

NCT ID: NCT05920850 Completed - Clinical trials for Lung Cancer Screening

The SHARED, Project, Lung Cancer Screening for African American Men (AAM)

Start date: July 14, 2023
Phase: N/A
Study type: Interventional

This study is a single-arm pre-test post-test design with a two-month follow-up assessment. The study aims to provide support to participants in quitting smoking and accessing lung cancer screening through the combination of education interventions and patient navigation (PN)

NCT ID: NCT05747443 Enrolling by invitation - Lung Cancer Clinical Trials

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

Larch
Start date: December 12, 2022
Phase: N/A
Study type: Interventional

Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.

NCT ID: NCT05645731 Recruiting - Lung Cancer Clinical Trials

Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study

Start date: May 12, 2023
Phase:
Study type: Observational

Lung cancer screening of active or former heavy smokers with yearly low-dose CT allows for earlier diagnosis and better lung cancer survival. Risk of developing lung cancer is higher among family members and close contacts of lung cancer patients, because of shared genetics, environment and life habits like smoking. The investigators want to engage lung cancer patients to refer their family members and close contacts for lung cancer screening, and evaluate if this referred population have higher risk of lung cancer than the population referred by their family doctors.

NCT ID: NCT05630950 Active, not recruiting - Clinical trials for Lung Cancer Screening

LDCT-SC-FI Low-dose CT Screening for Lung Cancer

Start date: November 18, 2022
Phase: N/A
Study type: Interventional

This is a randomized phase II trial investigating different smoking cessation methods in study subjects undergoing lung cancer screening with low-dose CT (LDCT). The study also evaluates feasibility and outcomes of LDCT screening and potential biomarkers and AI-based evaluation on CT-scans. The study subjects fulfilling I/E-criteria are randomized in 1:1 fashion to yearly LDCT for two rounds with standard smoking cessation (control) or same LDCT approach combined to mobile application based smoking cessation (intervention).

NCT ID: NCT05195385 Recruiting - Clinical trials for Lung Cancer Screening

Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study

CASCADE
Start date: April 8, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether reading of low-dose thoracic CT scans can be done by a single general radiologist who has been trained to lung cancer screening, and will evaluate the performance in comparison with double reading by experts. The study will enroll women between 50 and 74 years old, at risk for lung cancer due to their smoking history.

NCT ID: NCT04691297 Active, not recruiting - Smoking Cessation Clinical Trials

Digitally Enhanced Smoking Cessation for High Risk Smokers

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. In this research study involves Studying the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program compared to usual care. The ESCAPE program was developed help women with HIV quit smoking. Women in the ESCAPE program quit smoking and stayed quit for longer (up to 3 months). For this study, investigators have added a lung screening to the ESCAPE program and want to test if this will improve lung health through increasing quit rates and lung screening. .

NCT ID: NCT03958253 Completed - Clinical trials for Lung Cancer Screening

Lung Cancer Screening Protocol

I-STEP
Start date: April 22, 2019
Phase: N/A
Study type: Interventional

The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.

NCT ID: NCT03853967 Recruiting - Clinical trials for Lung Cancer Screening

Lung Cancer Screening by Low Dose CT Scan in a French Department (DEP KP80)

Start date: May 15, 2016
Phase: N/A
Study type: Interventional

Lung cancer is the leading cause of cancer death worldwide. The aims of this study were to assess the feasibility and effectiveness of a lung cancer screening pilot program with LD CT scan in a French department (Somme). DEP KP80 was a single-arm, prospective study started in May 2016. The inclusion criteria were those of the National Lung Screening Trial. An annual LD CT scan was scheduled and 2 rounds were planned. Smoking cessation was encouraged as part of the protocol. Subjects were selected by General Practitioner or Pneumologist who checked the inclusion criteria and prescribed the CT scan.